![Barry D. Garfinkle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barry D. Garfinkle
Director/Board Member at Arrevus, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert J. Schotzinger | M | 63 |
Arrevus, Inc.
![]() Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | 5 years |
Joseph T. McMahon | M | - |
Arrevus, Inc.
![]() Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | - |
Robert V. House | M | - |
Arrevus, Inc.
![]() Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | - |
Joseph W. St. Geme | M | - |
Arrevus, Inc.
![]() Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 4 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Barry D. Garfinkle
- Personal Network